Apple announced that researchers from Duke University, Johns Hopkins and Oregon Health & Science University are launching new medical studies using ResearchKit.
The smart mole scanner, which is designed to be attached to a smartphone's camera, is now live on crowdfunding website Indiegogo.
Said therapy will be evaluated in a clinical trial in France, and will involve an app and telemedicine services to monitor patients between doctor visits.
The company will use the funds to widen applications for its technology beyond moles and melanomas, and expand into new geographical markets.
Of the 206 respondents to the survey, 93% of whom were women, 63% said they strongly agreed with the safe and welcoming statement, while 24% somewhat agreed.
After the trial is completed, the company will produce a wearable device (iTBra), which will utilize a comfortable data collection device placed under a bra.
The setup involves a mini-microscope that attaches to a smartphone, an app and a HIPAA-compliant cloud-based analytical platform called DermEngine.
Polaris Health Directions and MD Anderson Cancer Center at Cooper are teaming-up to monitor patients' expected treatment response.
King's College Hospital will rely on Medopad's software to make it easier for patients to go through complicated treatment regimens.
Users should apply their blood sample in the designated spot, and let the device use a specialized microfluidic preparation system to extract a DNA sample.